688265 Stock Overview
Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Shanghai Model Organisms Center, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥26.56 |
| 52 Week High | CN¥47.97 |
| 52 Week Low | CN¥21.29 |
| Beta | 0.051 |
| 1 Month Change | -3.98% |
| 3 Month Change | 10.44% |
| 1 Year Change | -37.40% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -61.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688265 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 6.8% | 2.6% | 1.2% |
| 1Y | -37.4% | -34.9% | -12.6% |
Return vs Industry: 688265 underperformed the CN Life Sciences industry which returned -34.9% over the past year.
Return vs Market: 688265 underperformed the CN Market which returned -12.6% over the past year.
Price Volatility
| 688265 volatility | |
|---|---|
| 688265 Average Weekly Movement | 6.9% |
| Life Sciences Industry Average Movement | 9.1% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.1% |
| 10% least volatile stocks in CN Market | 5.0% |
Stable Share Price: 688265 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688265's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 737 | Mingjun Wang | www.modelorg.com |
Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. The company uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. It offers toolbox of mice; disease mice, such as rare, infectious, and nervous system diseases, as well as spontaneous tumor; and target humanized knockins, which includes tumor targets, immune checkpoint, complements, cytokines, and metabolic and other targets, as well as cytokine and viral infection receptor.
Shanghai Model Organisms Center, Inc. Fundamentals Summary
| 688265 fundamental statistics | |
|---|---|
| Market cap | CN¥2.07b |
| Earnings (TTM) | -CN¥19.25m |
| Revenue (TTM) | CN¥362.18m |
5.7x
P/S Ratio-107.6x
P/E RatioIs 688265 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688265 income statement (TTM) | |
|---|---|
| Revenue | CN¥362.18m |
| Cost of Revenue | CN¥206.07m |
| Gross Profit | CN¥156.10m |
| Other Expenses | CN¥175.35m |
| Earnings | -CN¥19.25m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.25 |
| Gross Margin | 43.10% |
| Net Profit Margin | -5.31% |
| Debt/Equity Ratio | 1.5% |
How did 688265 perform over the long term?
See historical performance and comparison